COMMUNIQUÉS West-GlobeNewswire

PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
09/04/2026
SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
09/04/2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]
Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth
09/04/2026
A veteran architect of Gemini’s Asia Pacific expansion, Ms. Gani joins to lead institutional buildout as Solana Company executes on its strategy to drive yield expansion, enhance revenue generation, advance business [...]
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
09/04/2026
RADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first quarter of 2026 [...]
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.
09/04/2026
EMPAVELI MD (pegcétacoplan) est le premier traitement autorisé dans le traitement des patients adultes et pédiatriques de 12 ans et plus atteints de glomérulopathie à dépôts de C3 (GC3) ou de glomérulonéphrite [...]
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
09/04/2026
EMPAVELI ® (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced proteinuria, [...]
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
09/04/2026
WINNIPEG, Manitoba, April 09, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced that it has partnered with the B.C. Provincial Health Services Authority (PHSA) to supply NARCAN ® Nasal Spray for [...]
Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want
09/04/2026
A new patient resource from a leading cosmetic dentist in Stamford, CT addresses the fears, misconceptions, and outdated beliefs that prevent adults from exploring modern cosmetic dentistry options. STAMFORD, CT, April [...]
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
09/04/2026
Not for distribution to U.S. news wire services or dissemination in the United States. MARKHAM, Ontario, April 09, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced [...]
Erratum: Correction du communiqué de presse publié le 7 avril 2026
09/04/2026
Le communiqué de presse publié le 7 avril 2026, relatif à l’acquisition d’actions propres, contenait les erreurs suivantes : Au troisième paragraphe, le nombre d’actions rachetées doit être “32.000 ” au lieu de “16.000 [...]
Erratum: Correction of press release published on April 7th, 2026
09/04/2026
The press release published on April 7 th , related to the acquisition of own shares, contained the following errors: In the third paragraph, the number of repurchased shares shall read “32,000” instead of “16,000”; In [...]
USA Today Names Aledade a 2026 Top Workplace for People-First Culture
09/04/2026
National award honors Aledade’s commitment to employee engagement and its mission-driven approach to advancing value-based care BETHESDA, Md., April 09, 2026 (GLOBE NEWSWIRE) -- Aledade , a physician-led, national [...]
Cynet Named Leader and Outperformer in 2026 GigaOm Radar for Extended Detection and Response (XDR)
09/04/2026
BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Cynet, the unified, AI-powered cybersecurity platform empowering organizations to focus on what matters most, has been named a Leader and Outperformer in the 2026 GigaOm Radar [...]
SOUND Behavioral Health Celebrates 60 Years of Service and Leadership in King County
09/04/2026
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- This year, SOUND Behavioral Health celebrates a remarkable milestone: 60 years of serving the people of King County with transformative mental health care, while standing with [...]
Biodesix Recognized as a Top Workplace for Third Consecutive Year
09/04/2026
Employee-Driven, Prestigious National Recognition for the Consistently High-Performing Biodesix Culture LOUISVILLE, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Biodesix is proud to announce that it has earned the [...]
BCAN Names Ferring Pharmaceuticals and the Astellas/Pfizer Alliance as National Presenting Sponsors of the 2026 Walks to End Bladder Cancer
09/04/2026
Partnerships fuel awareness, research and support for people impacted by bladder cancer Bethesda, MD, April 09, 2026 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) today announced that Ferring [...]
Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
09/04/2026
Planned interim analysis from DENALI Part 2a showed a clearly differentiated response rate at 400mg QD 5:2 over 300mg QD 5:2 and comparable safety profiles between the two dose groups Azenosertib therapeutic profile [...]
The Growing Connection Between Microplastics and the Human Heart
09/04/2026
Anathapindika Founder Speaks to Need for Detoxification in Supplementation: “Adding More Nutrients to Our Diets Is Not Enough for Healthy Living” Fort Lauderdale, FL, April 09, 2026 (GLOBE NEWSWIRE) -- The presence of [...]
Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
09/04/2026
BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]

Pages